THORNE RESEARCH, DR. MARK HOUSTON, AND THE HYPERTENSION INSTITUTE LAUNCH TRUCARDIAŽ – A NEW VENTURE TARGETING CARDIOVASCULAR HEALTH
TruCardiaŽ to offer nutritional supplements and resources to support patient cardiovascular health and better manage cardiovascular risk factors
SANDPOINT, IDAHO, December 5, 2013 – Thorne Research, Inc., a leader in developing and manufacturing pure, high-quality nutritional supplements marketed through licensed health-care practitioners, today announced that the company has partnered with Mark Houston, MD, MS, M.Sc, and the Hypertension Institute to launch TruCardiaŽ, a new venture providing novel nutritional supplements and educational programs to support and promote cardiovascular health. Dr. Houston will lead TruCardia's efforts to develop a range of nutritional supplements and patient resources. Dr. Houston is the Director of the Hypertension Institute, one of the nation's leading centers for cardiovascular health and a Cardiovascular Center of Excellence of the Consortium for Southeastern Hypertension Control, treating more than 20,000 patients each year.
The first product available from TruCardiaŽ is LipoCardia™, a nutritional supplement to help maintain healthy lipid levels. Three additional products will be launched in the first half of 2014: CardioPressin™, a nutritional supplement to support normal blood pressure levels, ArterioCare™, a nutritional supplement to support coronary artery blood flow and endothelial function to help maintain cardiovascular health, and MitoBio™, a nutritional supplement to help promote a healthier dynamic heart, enhance cardiac myocyte function, and promote mitochondrial biogenesis and function.
"Over 15 years of clinical research, experience, and clinical application have gone into the development of the TruCardiaŽ suite of nutritional supplements. Thorne Research, known for exceptional quality and purity, is a great partner in this endeavor," said Dr. Houston.
The TruCardiaŽ nutritional supplement product line was developed using the most advanced research technologies available for the support of cardiovascular health. A combination of peer-reviewed medical and scientific literature, metabolomics-based composition and molecular pathway analysis, clinical research, and expert insight was used to determine the range of ingredients and dosing levels to achieve optimal efficacy of the TruCardiaŽ nutritional supplement line.
"Cardiovascular disease is the single leading cause of death globally. By educating patients about the prudent use of nutritional supplements, nutrition, effective tools to monitor their cardiovascular health, and choosing healthier lifestyle options, we can help them better manage their risk of cardiovascular disease. There is significant medical evidence indicating that nutritional supplements can positively impact cardiovascular health. TruCardiaŽ will offer the finest educational and nutritional resources to make a difference in the lives of people who have cardiovascular disease or who may be at risk," said Dr. Houston.
In addition to offering high-quality nutritional supplements, TruCardiaŽ will also support efforts in cardiovascular research and provide specialized physician and patient education programs in cardiovascular health and prevention and the treatment of cardiovascular disease.
"Thorne Research is proud to offer high-quality, evidence-based nutritional supplements to health-care providers to help them support the cardiovascular health of their patients. We are pleased to be working with Dr. Houston to develop new resources that will help patients take an active role in maintaining their cardiovascular health. TruCardiaŽ is another important milestone for Thorne Research as we continue to expand our product portfolio and support the efforts of health-care providers to provide their patients with outstanding products backed by innovative programs in patient and clinician education," said Paul Jacobson, CEO, Thorne Research.
About Thorne Research, Inc.
Since 1984, Thorne Research, with more than 300 nutritional supplement products, has set the standard for exceptional quality manufacturing and formulation of advanced technology, pure, highly absorbable nutritional supplements. Thorne Research is recognized by health-care practitioners as a global leader and provider of nutritional supplements and education to licensed health-care practitioners. With locations in Sandpoint, Idaho, and New York City, Thorne Research operates a state-of-the-art manufacturing facility and employs more than 200 people. Further information on Thorne Research is available at www.thorne.com.
About Dr. Mark Houston
Dr. Houston is an Associate Clinical Professor of Medicine at Vanderbilt University School of Medicine and the Medical Director of the Division of Human Nutrition at Saint Thomas Hospital, in Nashville, Tennessee. He is triple board-certified in hypertension by the American Society of Hypertension (ASH, FASH), internal medicine (ABIM, FACP), and anti-aging and regenerative medicine (ABAARM, FAARM). He also has dual Masters of Science in Human Nutrition and Masters of Science in Medical Science of Metabolic and Nutritional Medicine. Dr. Houston is a Fellow of the American Heart Association (FAHA) and a Fellow of the American College of Nutrition (FACN). He specializes in the prevention and treatment of hypertension, dyslipidemia, and cardiovascular disease, and has a clinical and research practice in integrative cardiovascular medicine, preventive cardiology, vascular medicine, vascular biology, coronary heart disease, and congestive heart failure. He has pioneered multiple research efforts that demonstrate the effectiveness of nutritional supplements, optimal nutrition, exercise, weight management, and other lifestyle modifications to better manage cardiovascular conditions. Dr. Houston has published over 200 medical articles in peer-reviewed journals, serves on the editorial board for numerous cardiovascular journals, has completed over 120 clinical research studies in cardiovascular disease, and presented over 10,000 lectures worldwide. He has authored several best-selling books including: "What Your Doctor May Not Tell You About Hypertension," "What Your Doctor May Not Tell You About Heart Disease," and "The Handbook of Hypertension." He has been selected by both USA Today and the Consumers Research Council as one of the Top and Most Influential Physicians in Hypertension and Dyslipidemia in the United States.
About the Hypertension Institute
The Hypertension Institute of Nashville, Tennessee, specializes in the prevention, diagnosis, and management of hypertension (high blood pressure), cardiovascular disease, dyslipidemia, vascular aging, and their complications. It provides patients with the latest clinical research, patient care, education, sophisticated cardiovascular specialty primary care, and hypertensive, dyslipidemia, and heart disease treatments. The Hypertension Institute strives to prevent complications such as coronary heart disease, angina, myocardial infarction (heart attack), congestive heart failure, kidney disease, and cerebrovascular accidents (stroke). It is through in-depth consultation, examination, and non-drug and drug treatment that patients are able to permanently modify their lifestyles and reduce cardiovascular risk. The Hypertension Institute offers specialized programs in nutrition; nutritional supplements; exercise, stress management, and weight loss; diagnostic labs; and advanced cardiovascular testing, as well as a Facial Rejuvenation Center (FRC).
Berry & Company Public Relations
Ph. +1 212-253-8881
July 7, 2013 – Thorne Research Makes Major Gift to Foundations of Naturopathic Medicine Project
Partnership will include collaboration to support quality of life during healing for oncology patients. (read more)
April 30, 2013 – Thorne Research and YouCare Pharmaceutical Group Announce Joint Venture Deal to Market Nutritional Supplements in China
Collaboration positions wide range of natural health products manufactured by Thorne Research for sale in rapidly expanding Chinese market. (read more)
February 22, 2013 – Thorne Research and HerbalScience Group Announce Discovery and Development Deal for Line of Natural Health Products
Collaboration expands Thorne Research focus on discovering, developing, producing and commercializing high quality natural health products for global markets. (read more)
September 18, 2012 – Thorne Research Launches Thorne Performance, a New Venture in Sports Nutrition
In collaboration with Integrative Health Resources, Thorne Research will develop and commercialize a dietary supplement product line and nutritional tools to support a healthy athletic lifestyle. (read more)
July 31, 2012 – Thorne Research, Inc., and Helsinn Healthcare SA Announce Oncoqol™ – A Joint Effort to Provide Nutritional Supplements and Personal Care Products to Patients Undergoing Cancer Treatment
OncoQOL nutritional supplements and personal care products are now available through oncologists and other medical professionals in the United States and Canada to help patients address nutritional issues and side effects associated with treatment for different types of cancer. (read more)
July 25, 2012 – Thorne Research, Integrative Health Resources and Dr. Daniel G. Amen Launch New Venture Targeting Cognitive Health
Venture to develop portfolio of supplements, nutritional tools and exercises to support healthy brain function.(read more)
October 4, 2011 – Thorne Research and Indena Enter into Strategic Cooperation
Two leading companies in nutritional supplements and botanicals to restore and improve health join together to develop and commercialize innovative and scientifically validated botanical dietary supplements.(read more)
August 12, 2011 – Thorne Research Acquires Exclusive Global Rights To Advanced Formulation Of Coenzyme Q10
All-natural softgel formulation QCell™ shown to be more absorbent and bioavailable compared to other coenzyme Q10 supplements.(read more)
May 11, 2011 – Helsinn Group Invests in Thorne Research and Will Jointly Pursue the Development of Nutritional Products, Information and Support Services in Cancer Care
Helsinn Group makes an equity investment for a minority interest in Thorne Research, Inc. and plans to jointly commercialize nutritional supplement products with initial focus on meeting the needs of people living with cancer. (read more)
April 15, 2011 – Thorne Research and Integrative Health Resources Establish Joint Venture to Provide Full Range of Services in Practice Development, Patient and Clinician Education, and Access to Nutritional Supplements in Integrative Medicine
Health Elements established as the first service to offer a comprehensive web-based solution to support medical practices and their patients with integrative medical information and education, patient adherence and wellness programs, health and lifestyle recommendations, dietary supplement sourcing, and innovative product development. (read more)
February 16, 2011 – Thorne Research is Proud to Announce the Launch of Thorne Vet!
Thorne Research is proud to announce the launch of Thorne Vet, dedicated to serving the needs of the companion pet and equine markets. (read more)
June 24, 2010 – Thorne Research Announces Combination with Diversified Natural Products
Thorne Research, Inc. announced that it has merged with Diversified Natural Products (DNP). The combination of the two companies joins the clinically researched product portfolio of DNP with the hypo-allergenic, exceptionally formulated product line of Thorne. (read more)
Everyone has become accustomed to seeing the vague "We use only the purest ingredients" in the promotional material of almost every dietary supplement company. What's the real story?